What Are Your Thoughts on Microdosing?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

The FDA doesn't really like the idea of just giving someone a bottle of LSD pills and saying, go home and take these every day. The data we do have on microdosing is largely anecdotal. There are lots of observational studies where they do surveys of people but there's no way to know. We do not have enough evidence to reject the null hypothesis. I'm sure at some point someone will prove that some form of microdoses is good for something but we just don't know yet.

Brom Rector is the founder of Empath Ventures, a VC fund that in invests in early-stage psychedelics startups. Prior to founding Empath, Brom sent several years as a portfolio manager and quantitative researcher. Brom joins the show to discuss the current state of the psychedelics industry, the lessons learned founding a VC fund, the differences between psychedelics and cannabis, and a whole lot more. Important Links:

Show Notes:

How Brom became interested in psychedelic investing
Psychedelics and the mental health epidemic
Depoliticising psychedelics
Empath Ventures’ business model
How we can scientifically improve psychedelics
The influence of hippie culture
A contrarian view on Big Pharma
The potential benefits of ibogaine
The differences between cannabis and psychedelics
Do some people not react to psychedelics?
Brom’s thoughts on microdosing
Lessons learned from founding a VC company
The benefits of Rule 506(c)

Books Mentioned:

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence; by Michael Pollan
Healing Back Pain: The Mind-Body Connection; by John E. Sarno MD